Insider Trades of SCHOEMAKER KATHLEEN K Information

Click on the column header to resort 'ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date Type Tran OwnerType Shares Traded Last Price Shares Held ▼
ACHILLION PHARMACEUTICALS INC Beneficial Owner (10%) 05/31/2012 Form 4 Disposition (Non Open Market) indirect 1,200,000 0 6,772,968
ACHILLION PHARMACEUTICALS INC Beneficial Owner (10%) 01/18/2013 Form 4 Disposition (Non Open Market) indirect 1,000,000 0 5,772,968
TANDEM DIABETES CARE INC Beneficial Owner (10%) 11/19/2013 Form 4 Acquisition (Non Open Market) indirect 3,243,448 0 3,189,058
VERACYTE, INC. Beneficial Owner (10%) 11/04/2013 Form 4 Acquisition (Non Open Market) indirect 3,086,024 0 3,063,294
DURATA THERAPEUTICS, INC. Beneficial Owner (10%) 07/24/2012 Form 4 Buy indirect 784,313 9 3,006,132
REGADO BIOSCIENCES INC Beneficial Owner (10%) 08/27/2013 Form 4 Buy indirect 750,000 4 2,571,117
DURATA THERAPEUTICS, INC. Beneficial Owner (10%) 07/24/2012 Form 4 Acquisition (Non Open Market) indirect 2,244,125 0 2,227,596
ESPERION THERAPEUTICS, INC. Beneficial Owner (10%) 07/01/2013 Form 4 Buy indirect 285,714 14 2,066,935
ACHAOGEN INC Beneficial Owner (10%) 03/17/2014 Form 4 Acquisition (Non Open Market) indirect 2,020,939 0 1,987,049
REGADO BIOSCIENCES INC Beneficial Owner (10%) 08/27/2013 Form 4 Acquisition (Non Open Market) indirect 1,800,109 0 1,821,117
ESPERION THERAPEUTICS, INC. Beneficial Owner (10%) 07/01/2013 Form 4 Acquisition (Non Open Market) indirect 1,816,474 0 1,786,012
DICERNA PHARMACEUTICALS INC Beneficial Owner (10%) 02/04/2014 Form 4 Acquisition (Non Open Market) indirect 1,765,711 0 1,752,707
EVOKE PHARMA INC Beneficial Owner (10%) 09/30/2013 Form 4 Acquisition (Non Open Market) indirect 1,133,333 0 1,114,327
ACHILLION PHARMACEUTICALS INC Beneficial Owner (10%) 01/18/2013 Form 4 Acquisition (Non Open Market) indirect 66,462 0 159,896
ACHILLION PHARMACEUTICALS INC Beneficial Owner (10%) 05/31/2012 Form 4 Acquisition (Non Open Market) indirect 93,434 0 93,434